Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: A Phase III, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Clinical Efficacy and Safety of DiaPep277® in Newly Diagnosed Type 1 Diabetes Subjects

 


A Phase III, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Clinical Efficacy and Safety of DiaPep277® in Newly Diagnosed Type 1 Diabetes Subjects


New-Onset Type 1 Diabetes in Adults

Trial Focus

Trial Focus

Diabetes, Drugs (Pharmacology)

Objective

        

IRB Protocol #

10-1406

Trial Status

Accepting Participants

Contact

Elizabeth Cohlmia at 303-724-3974 or elizabeth.cohlmia@ucdenver.edu

Eligibility and Other Participant Information